Postdural Puncture Headache Clinical Trial
Official title:
Effect of Intravenous Versus Intrathecal Dexamethazone in Bupivacaine Spinal Anesthesia on Postdural Puncture Headache
This study will be conducted at Ain Shams University Hospital in Operating Theatre after ethical committe approval number (MS 32/ 2020). It is a prospective randomized controlled study will be done on patients undergoing lower abdominal and lower limb surgeries under spinal anethesia,Eligible patients will be randomized by computer system to one of two groups, either intravenous dexamethazzoe 8 mg with intrathecal heavy bupivacaine 0.5% or intrathecal 4mg dexamethazone with intrathecal heavy bupivacaine 0.5%. .
Patients will be randomly divided into two equal groups: Group 1: patients receive intrathecal 3 ml bupivacaine 0. 5% +1 ml normal saline + intravenous 8 mg dexamethazone in 10 ml saline. Group 2: patients receive intrathecal 3 ml bupivacaine 0. 5% + 4 mg (1 ml) dexamethazone + intravenous 10 ml normal saline. Upon patients' arrival into the operating room, peripheral oxygen saturation (SPO2), ECG, pulse rate (PR), and systolic and diastolic blood pressures will be monitored one of the researchers and recorded every 5 minutes till the end of surgery. In a sitting position and with antiseptic techniques, 25 G Quincke needle was inserted intrathecally at L3-L4 or L4-L5 interspace through midline approach. The study drugs were given by an anesthesiologist not not aware of the type of medications injected. Subsequently, the patients were put in the supine position, and given oxygen 3 L/minutes by nasal prongs. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03112720 -
Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache
|
Phase 3 | |
| Suspended |
NCT02473276 -
2 Dose Neuraxial Morphine for Prevention of PDPH
|
Phase 4 | |
| Completed |
NCT03652714 -
The Effect of Ganglion Sphenopalatine Block (GSP-block) Versus Placebo on Postdural Puncture Headache
|
Phase 3 | |
| Completed |
NCT02859233 -
Role of Prophylaxis by Oral Fluid Supplementation in Prevention of Postdural Puncture Headache
|
N/A | |
| Withdrawn |
NCT02181205 -
Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
|
N/A | |
| Completed |
NCT01977898 -
Incidence of Headache Following an Unintentional Dural Puncture
|
N/A | |
| Completed |
NCT06394024 -
Examination of Postdural Puncture Headache Frequency, Predisposing Factors and Treatment
|
||
| Withdrawn |
NCT03966547 -
Changes in Cerebral Blood Flow (CBF) in Prone and Sitting Position Before and After GSP-block and Before and After Epidural Blood-patch: A Substudy of NCT03652714
|
N/A | |
| Completed |
NCT06380764 -
Greater Occipital Nerve Block Value in Management of Postdural Puncture Headache
|
N/A | |
| Terminated |
NCT02365909 -
Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)
|
Early Phase 1 | |
| Completed |
NCT04910477 -
Nebulized Dexmedetomidine Versus Neostigmine/Atropine in Postdural Puncture Headache
|
Phase 3 | |
| Completed |
NCT05969119 -
Addition of Pyridostigmine to Conventional Management of Postdural Puncture Headache
|
Phase 4 | |
| Completed |
NCT02150304 -
Aminophylline Prophylaxis For Postdural Puncture Headache
|
N/A | |
| Withdrawn |
NCT02517931 -
Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department
|
N/A | |
| Recruiting |
NCT06271486 -
Pregabalin in Treatment of Postdural Puncture Headache
|
Phase 3 | |
| Completed |
NCT00465166 -
Lumbar Spine Ultrasound of Patients With Previous Accidental Dural Puncture During Labour Epidural
|
N/A | |
| Not yet recruiting |
NCT05212194 -
The Relationship Between Post Dural Puncture Headache and Joint Laxity
|
N/A | |
| Completed |
NCT05777694 -
Postdural Punction Headache After Ceserian Section
|
N/A | |
| Withdrawn |
NCT04515901 -
Spenopalatine Ganglion Block for Treatment of Post-dural Puncture Headaches
|
N/A | |
| Completed |
NCT04892290 -
Sphenopalatine Ganglion Block for Postdural Puncture Headache
|